NanoSpeed Announces Global Distribution Partnership with DiaSys Diagnostics Systems for Test4D™

NanoSpeed LogoEdmonton, Alberta — (March 2, 2015)NanoSpeed Diagnostics, Inc. (“NanoSpeed”) is pleased to announce an expansion of their exclusive distribution agreement with global diagnostics and instrumentation distributor, DiaSys Diagnostics Systems GmbH (“DiaSys”), to market their 25-OH Vitamin D deficiency test kit.  Under the broadened agreement, DiaSys will market the point-of-care vitamin D test under their own brand, QDx™, worldwide except in those territories that are already part of NanoSpeed’s network and certain other territories.  DiaSys is a large point-of-care diagnostics technology company with locations in Europe, Asia and Latin America selling to over 100 countries.

“An important element of positioning our point-of-care vitamin D test to meet the needs of patients is having broad and diverse distribution,” said Dr. Seema Gupta, President of NanoSpeed Diagnostics, Inc., a leading diagnostics company focused on providing portable, innovative and rapid testing solutions.  “DiaSys has tremendous global reach and an unparalleled passion for safe and high-quality tests to bring the best result for patients.  This agreement is an important milestone for our company and patient access to our vitamin D test.  We would like to acknowledge the assistance of TEC Edmonton for their business development support.”

Technical support, advisory services and financial support from the National Research Council of Canada Industrial Research Assistance Program (“NRC-IRAP”), along with the contributions from Western Economic Diversification and Alberta Innovates – Technology Futures, were crucial to the success of NanoSpeed and its products.

NanoSpeed’s vitamin D test is a patented and unique point-of-care test that provides information on Vitamin D deficiency within 10 minutes.  This test requires only a single drop of blood from the patient and costs 90% less when compared to other standard or conventional tests.

Test4D® and QDx™ are not approved for commercial use in Canada or the United States and is limited by federal law to research or investigational use only.


About DiaSys Diagnostics Systems GmbH

DiaSys Diagnostic Systems is a leading specialist in the development and manufacturing of diagnostic system solutions of highest quality, trusted by customers in more than 100 countries for over 20 years. Our product portfolio comprises more than 90 clinical chemistry and immunoturbidimetric reagents for routine and special diagnostics including suitable calibrators and controls. The DiaSys instrumentation product range covers automated clinical chemistry analyzers, semi-automated analyzers and point of care (POC) instruments for near-patient testing.

DiaSys decided to focus further into POC: this strategic investment with global intent includes R&D, manufacturing and a portfolio of solutions, recently presented, under the QDx brand.

For more information, please visit


About NanoSpeed Diagnostics Inc.

NanoSpeed, incorporated in 2009, develops proprietary diagnostic/screening test kit platforms based on their Lateral Flow Immuno Assay and Lab-on-a-Chip technologies. These technological advancements provide patients with cost effective and reliable testing tools that will address the increasing needs of the healthcare industry, regulatory agencies and consumers.

About Vitamin D deficiency and Test4D™:
Vitamin D deficiency is a common problem in Canada, where 60% of adults have suboptimal levels of 25-OH vitamin D. Vitamin D deficiency has been associated with abnormalities in absorption of calcium, phosphorus, and bone metabolism; cardiovascular disease; diabetes; cancer; osteomalacia and osteoporosis in adults; and rickets in children. Deficient vitamin D levels are typically the result of an inadequate intake of vitamin D through sunlight, diet, or supplements, or due to malabsorptive disorders.

25-OH vitamin D levels are currently measured through laboratory testing. Over the past decade, there has been an incremental surge in the demand for vitamin D testing, resulting in increasing costs to government supported healthcare systems. An alternative to laboratory testing is Point-of-Care-Testing (POCT), medical testing that occurs outside of a clinical laboratory and near the patient. Potential advantages of POCT include reduction in errors and costs to the healthcare system, and the provision of quick clinical diagnoses.

To address the demands of vitamin D testing, NanoSpeed Diagnostics Inc. developed Test4D™, a POCT device for the qualitative detection of 25-OH Vitamin D in human blood obtained via fingertip puncture.

Test4D™ is available for commercial sale through certain distributors, or can be purchased for research purposes directly from NanoSpeed.



NanoSpeed Diagnostics Inc.
Seema Gupta, 780-701–0022 x 222